Athersys Free Cash Flow:
-3.683M for Dec. 31, 2012Athersys Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -3.683M |
| Sept. 30, 2012 | -3.684M |
| June 30, 2012 | -5.022M |
| March 31, 2012 | -5.623M |
| Dec. 31, 2011 | -4.507M |
| Sept. 30, 2011 | -4.349M |
| June 30, 2011 | -4.358M |
| March 31, 2011 | -1.865M |
| Dec. 31, 2010 | -2.605M |
| Sept. 30, 2010 | -2.217M |
| June 30, 2010 | -2.339M |
| March 31, 2010 | -3.82M |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
ATHX Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Osiris Therapeutics | -4.696M |
| Cleveland BioLabs | -5.218M |
| Celgene Corporation | 341.20M |
ATHX Free Cash Flow Rankings
| Overall |
59th percentile 3244 of 8002 |
| Sector |
44th percentile 361 of 650 in Healthcare |
| Industry |
67th percentile 78 of 237 in Biotechnology |
ATHX Free Cash Flow Range, Past 5 Years
| Minimum | -5.623M | Mar 2012 |
| Maximum | 4.017M | Dec 2009 |
| Average | -3.221M |
